In This Article:
Originally published in Quest Diagnostics' 2023 Corporate Responsibility Report
NORTHAMPTON, MA / ACCESSWIRE / December 23, 2024 / For more than 56 years, Quest has been a leading provider of diagnostic information services with over 70 billion data points based on de-identified patient results. Robust corporate governance has been crucial to our success.
Our Board of Directors and Executive Leadership guide our high standards of business ethics and integrity, including in our supply chain. The Board oversees our ESG and critical business priorities by establishing governance structures that create accountability, affirm leadership commitment to these issues, and help us deliver best-in-class care to our patients.
Governance and ethics
2025/2026 goals
-
Expand ESG risk assessments of key suppliers that comprise the majority of our total spend
-
Grow our spend with small and diverse suppliers in the US to $500 million by 2026
2023 progress
-
Over 53% of suppliers based on annual spend successfully completed their assessments
-
Quest purchased $343 million in goods and services from small and diverse US businesses
Governance
Quest's corporate governance structure helps us maintain high-integrity operating standards in everything we do.
Our executive leadership team adopts and executes policies and procedures that promote ethical, transparent, and purposeful business practices. Our Board of Directors oversees our executive leadership team and receives regular, quarterly updates on progress toward our identified priorities and objectives, including our ESG goals.
BOARD OF DIRECTORS*
The expertise of our Board of Directors helps us operate with the ambition and excellence our customers, employees, shareholders, and other stakeholders expect. Of Quest's Board members:
-
50% are women and/or represent a diverse race/ethnicity
-
9 members are independent
Learn more about our Board of Directors and their experience.
BOARD COMMITTEES
The Board regularly reviews information regarding our business and industry through 6 committees.
-
Audit & Finance: Monitors the quality and integrity of Quest's financial statements and related disclosures and advises with regard to certain financing transactions and other significant financial policies and actions. Oversees compliance with securities and accounting laws and regulations, the internal audit function, audits by the independent registered public accounting firm, and enterprise risk management.
-
Compensation & Leadership Development: Reviews and approves corporate goals and objectives relevant to the compensation of the CEO and evaluates the performance of the CEO in light of those goals. Oversees the implementation of the total compensation package for Quest's executive leadership team and reviews the long-term incentive and equity compensation plans for employees, supports the Board in succession planning for Quest's CEO and senior management, and oversees talent management and leadership development.
-
Cybersecurity: Oversees Quest's cybersecurity policies, plans, programs and practices, and risks related to cybersecurity and data security. Reviews compliance with related legal and regulatory requirements.
-
Executive: May act for the Board, except with respect to certain major corporate matters such as mergers, the appointment of directors to fill vacancies, removal of the CEO, amendment of Quest's certificate of incorporation or by-laws, declaration of dividends, and matters delegated to other Board committees.
-
Governance: Identifies and recommends Board director nominees for election, assists the Board in the oversight of ESG matters, and monitors developments in corporate governance. Oversees the Board and Board committees' annual self-evaluation processes and engagement efforts with stockholders and other key stakeholders.
-
Quality & Compliance: Reviews Quest's compliance program and department, medical quality assurance programs and performance, and government affairs program. Monitors legal matters and compliance with legal and regulatory requirements, as well as significant investigations as they relate to possible violations of the law or medical quality complaints.